Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

80%

4 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4

4(80.0%)

Early Phase 1

1(20.0%)

5Total

Phase 4(4)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT02682147Phase 4Active Not Recruiting

Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema

Role: lead

NCT03382106Phase 4Completed

Smoking Cessation and Functional CT Assessment

Role: lead

NCT03776747Phase 4Completed

Repeatability in Hyperpolarized 3-Helium With MRI

Role: lead

NCT03733470Phase 4Completed

Hypoxic Pulmonary Vasoconstriction Pilot Study

Role: lead

NCT03764163Early Phase 1Completed

Image and Model Based Analysis of Lung Disease

Role: lead

All 5 trials loaded